Drug retention of secondary biologics or JAK inhibitors after tocilizumab or abatacept failure as first biologics in patients with rheumatoid arthritis -the ANSWER cohort study-

被引：0
作者：
Kosuke Ebina
Toru Hirano
Yuichi Maeda
Wataru Yamamoto
Motomu Hashimoto
Koichi Murata
Tohru Takeuchi
Koji Nagai
Yonsu Son
Hideki Amuro
Akira Onishi
Sadao Jinno
Ryota Hara
Masaki Katayama
Keiichi Yamamoto
Atsushi Kumanogoh
Makoto Hirao
机构：
[1] Osaka University,Department of Musculoskeletal Regenerative Medicine, Graduate School of Medicine
[2] Osaka University,Department of Respiratory Medicine and Clinical Immunology, Graduate School of Medicine
[3] Kurashiki Sweet Hospital,Department of Health Information Management
[4] Kyoto University,Department of Advanced Medicine for Rheumatic diseases, Graduate School of Medicine
[5] Osaka Medical College,Department of Internal Medicine (IV)
[6] Koshokai Aino Hospital,Rheumatology center
[7] Kansai Medical University,First Department of Internal Medicine
[8] Kobe University Graduate School of Medicine,Department of Rheumatology and Clinical Immunology
[9] Nara Medical University,The Center for Rheumatic Diseases
[10] Osaka Red Cross Hospital,Department of Rheumatology
[11] Wakayama Medical University Hospital,Department of Medical Informatics
[12] Osaka University,Department of Orthopaedic Surgery, Graduate School of Medicine
来源：
Clinical Rheumatology | 2020年 / 39卷
关键词：
Abatacept; Biologics; Drug retention; Janus kinase inhibitors; Rheumatoid arthritis; Tocilizumab;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2563 / 2572
页数：9
相关论文
共 50 条
[21]   Risk of malignancy associated with use of tocilizumab versus other biologics in patients with rheumatoid arthritis: A multi-database cohort study [J].
Kim, Seoyoung C. ;
Pawar, Ajinkya ;
Desai, Rishi J. ;
Solomon, Daniel H. ;
Gale, Sara ;
Bao, Min ;
Sarsour, Khaled ;
Schneeweiss, Sebastian .
SEMINARS IN ARTHRITIS AND RHEUMATISM, 2019, 49 (02) :222-228
[22]   Abatacept and tocilizumab tapering in rheumatoid arthritis patients: results of SONATA-a retrospective, exploratory cohort study [J].
Bouman, Chantal A. M. ;
Tweehuysen, Lieke ;
Haverkort, Dieneke ;
van den Ende, Cornelia H. ;
van der Maas, Aatke ;
den Broeder, Alfons A. .
RHEUMATOLOGY ADVANCES IN PRACTICE, 2018, 2 (01) :1-10
[23]   Use and effectiveness of tocilizumab among patients with rheumatoid arthritis: an observational study from the British Society for Rheumatology Biologics Register for rheumatoid arthritis [J].
Kihara, Mari ;
Davies, Rebecca ;
Kearsley-Fleet, Lianne ;
Watson, Kath D. ;
Lunt, Mark ;
Symmons, Deborah P. M. ;
Hyrich, Kimme L. .
CLINICAL RHEUMATOLOGY, 2017, 36 (02) :241-250
[24]   Use and effectiveness of tocilizumab among patients with rheumatoid arthritis: an observational study from the British Society for Rheumatology Biologics Register for rheumatoid arthritis [J].
Mari Kihara ;
Rebecca Davies ;
Lianne Kearsley-Fleet ;
Kath D. Watson ;
Mark Lunt ;
Deborah P.M. Symmons ;
Kimme L. Hyrich .
Clinical Rheumatology, 2017, 36 :241-250
[25]   Comparison of the clinical effectiveness of tumour necrosis factor inhibitors and abatacept after insufficient response to tocilizumab in patients with rheumatoid arthritis [J].
Mitsuhiro Akiyama ;
Yuko Kaneko ;
Harumi Kondo ;
Tsutomu Takeuchi .
Clinical Rheumatology, 2016, 35 :2829-2834
[26]   Comparison of the clinical effectiveness of tumour necrosis factor inhibitors and abatacept after insufficient response to tocilizumab in patients with rheumatoid arthritis [J].
Akiyama, Mitsuhiro ;
Kaneko, Yuko ;
Kondo, Harumi ;
Takeuchi, Tsutomu .
CLINICAL RHEUMATOLOGY, 2016, 35 (11) :2829-2834
[27]   A review of tocilizumab treatment in 122 rheumatoid arthritis patients included in the Tsurumai Biologics Communication Registry (TBCR) Study [J].
Yabe, Yuichiro ;
Kojima, Toshihisa ;
Kaneko, Atsushi ;
Asai, Nobuyuki ;
Kobayakawa, Tomonori ;
Ishiguro, Naoki .
MODERN RHEUMATOLOGY, 2013, 23 (02) :245-253
[28]   Comparative risk of osteoporotic fracture among patients with rheumatoid arthritis receiving TNF inhibitors versus other biologics: a cohort study [J].
Shin, A. ;
Park, E. H. ;
Dong, Y-H ;
Ha, Y-J ;
Lee, Y. J. ;
Lee, E. B. ;
Song, Y. W. ;
Kang, E. H. .
OSTEOPOROSIS INTERNATIONAL, 2020, 31 (11) :2131-2139
[29]   Effectiveness and safety of tocilizumab in achieving clinical and functional remission, and sustaining efficacy in biologics-naive patients with rheumatoid arthritis: The FIRST Bio study [J].
Ishiguro, Naoki ;
Atsumi, Tatsuya ;
Harigai, Masayoshi ;
Mimori, Tsuneyo ;
Nishimoto, Norihiro ;
Sumida, Takayuki ;
Takeuchi, Tsutomu ;
Tanaka, Yoshiya ;
Nakasone, Ayako ;
Takagi, Nobuhiro ;
Yamanaka, Hisashi .
MODERN RHEUMATOLOGY, 2017, 27 (02) :217-226
[30]   JAK INHIBITORS VS BIOLOGICS FOR RHEUMATOID ARTHRITIS: PRELIMINARY RESULTS FROM A BRAZILIAN OBSERVATIONAL REAL-WORLD COHORT [J].
Carvalho De Oliveira, Lucas Moyses ;
Brandao de Resende Guimaraes, Maria Fernanda ;
Pinto, Maria Raquel da Costa ;
Calderaro, Debora Cerqueira .
JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2023, 29 :S77-S77
12345